AlphaFold predicted structure
ROR1 · Q01973

Mean pLDDT
68.2/ 100
Low
937 residues
Confidence breakdown
- Very high(≥ 90)25%
- Confident(70–90)34%
- Low(50–70)9%
- Very low(< 50)32%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
ROR family WNT receptor 1
Annotations refreshed 1 month ago.
Moderate Evidence (Amber)
Monogenic hearing loss
BIALLELIC, autosomal or pseudoautosomalhearing loss, autosomal recessive
Abnormality of the skeletal system
cervical carcinoma
diffuse large B-cell lymphoma
mantle cell lymphoma
thrombophilia
knee fracture
deafness
fracture of pelvis
septic shock
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Inactive tyrosine-protein kinase transmembrane receptor ROR1
Has very low kinase activity in vitro and is unlikely to function as a tyrosine kinase in vivo (PubMed:25029443). Receptor for ligand WNT5A which activates downstream NFkB signaling pathway and may result in the inhibition of WNT3A-mediated signaling (PubMed:25029443, PubMed:27162350). In the inner ear, crucial for spiral ganglion neurons to innervate auditory hair cells (PubMed:27162350). Via IGFBP5 ligand, forms a complex with ERBB2 to enhance CREB oncogenic signaling (PubMed:36949068)
Curated MONDO disease pages that list ROR1 among their top associated genes.
ROR1 · Q01973

Mean pLDDT
68.2/ 100
Low
937 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0